About Estro Pharmaceuticals Private Limited
Data last updated:
Estro Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24232BR2012PTC018014. Its GSTIN is 10AACCE9483G1ZQ (Bihar). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1.5 Lakh. It was formerly known as Estro Pharma Private Limited. It is led by directors including Babloo Prasad Upadhyay and Jayendra Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Infront Of N.T.P.C (Phase – 1) Ashiana Nagar, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.49 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹15.57 Lakh (net margin 4.5%) and EBITDA of ₹38.85 Lakh (EBITDA margin 11.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website estropharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressInfront Of N.T.P.C (Phase – 1) Ashiana Nagar, Patna, Bihar, India – 800001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Estro Pharmaceuticals Private Limited
The main business activity of Estro Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals Private Limited is audited by Barun & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Barun & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babloo Prasad Upadhyay | Director | 18 Jan 2012 | 14 Years 8 Months | Current |
| Jayendra Sinha | Director | 10 Mar 2014 | 12 Years 6 Months | Current |
| Dinesh Pratap Singh Also directs: Foxglove Connect Private Limited | Additional Director | 09 Aug 2023 | 3 Years 1 Months | Current |
Financials of Estro Pharmaceuticals Private Limited FY 2025 filings available
Estro Pharmaceuticals Private Limited reported revenue of ₹3.49 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Estro Pharmaceuticals Private Limited
Revenue rose 30% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Estro Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹38.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.57 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Estro Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Estro Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Estro Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals Private Limited has a workforce of 29 employees as of Oct 08, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCE9483G1ZQ | Bihar | Active | 01 Jul 2017 |
| 07AACCE9483G1ZD | Delhi | Active | 09 Jan 2018 |
| 09AACCE9483G1Z9 | Uttar Pradesh | Active | 08 Oct 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals Private Limited has 4 court cases on record: 4 filed by Estro Pharmaceuticals. 3 cases are pending and 1 is disposed. Status as checked between 30 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 3 |
Cases on record (2 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Pending |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against individuals | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Estro Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Estro Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Estro Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Estro Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Estro Pharmaceuticals Private Limited
Frequently Asked Questions about Estro Pharmaceuticals Private Limited
Estro Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2012 (14+ years old) and is registered under CIN U24232BR2012PTC018014.
Estro Pharmaceuticals reported revenue of ₹3.49 Cr for FY 2025 (up 30% YoY).
Estro Pharmaceuticals has 3 current directors:
- Babloo Prasad Upadhyay - Director
- Jayendra Sinha - Director
- Dinesh Pratap Singh - Additional Director
Estro Pharmaceuticals reported a net profit of ₹15.57 Lakh (net margin 4.5%) and EBITDA of ₹38.85 Lakh (EBITDA margin 11.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Estro Pharmaceuticals is -7% over five years. In the latest year (FY 2025) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Estro Pharmaceuticals is 10AACCE9483G1ZQ, registered in Bihar. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 07AACCE9483G1ZD (Delhi), 09AACCE9483G1Z9 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Estro Pharmaceuticals is U24232BR2012PTC018014. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Estro Pharmaceuticals has 4 court cases on record: 4 filed by the company. 3 are pending.
Estro Pharmaceuticals was incorporated on 18 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Patna.